Plerixafor And G-Csf Combination Mobilizes Hematopoietic Stem And Progenitors Cells With A Distinct Transcriptional Profile And A Reduced In Vivo Homing Capacity Compared To Plerixafor Alone
HAEMATOLOGICA(2017)
摘要
For decades, bone marrow (BM) has been the preferred source of hematopoietic stem and progenitor cells (HSPCs) for transplants following myeloablative conditioning. At present, mobilized peripheral blood stem cells are commonly used for transplantation, particularly in the autologous setting.[1][1
更多查看译文
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要